MONDAY, Oct. 28 (HealthDay News) -- When the U.S. Food and Drug Administration whisks new drugs to market, they do get to patients faster. But they are often not tested as strictly as treatments that get standard reviews, a new study shows. The re...
Source: http://health.yahoo.net/news/s/hsn/key-safety-questions-may-linger-for-fda-expedited-drugs
as example as an example explained here as explained here
No comments:
Post a Comment
Note: only a member of this blog may post a comment.